The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Identification of a tumor‐initiating stem cell population in human renal carcinomas
Abstract
The purpose of the present study was to search for the presence of a tumor‐initiating stem cell population in renal carcinomas. Based on the recent identification of mesenchymal stem cells in normal kidneys, we sorted cells expressing the mesenchymal stem cell marker CD105 from 5 human renal carcinomas. Because the CD105 + but not the CD105 − population showed enhanced tumorigenicity when injected in severely compromised immunodeficient (SCID) mice, we cloned and characterized CD105 + cells and evaluated their stemness, differentiative ability, and serial tumor generation. Characterization of the phenotype of CD105 + clones revealed several stem cell properties: 1 ) clonogenic ability, 2 ) expression of nestin, Nanog, Oct4 stem cell markers, and lack of differentiative epithelial markers, 3 ) ability to grow in non‐adhesive spheroids, 4 ) in vitro differentiation into epithelial and endothelial cell types, and 5 ) generation in vivo of serially transplantable carcinomas containing an undifferentiated CD105 + tumorigenic and a differentiated CD105 − nontumorigenic population. In addition, some vessels present in carcinomas generated from CD105 + clones were of human origin, suggesting the capability of tumor‐initiating stem cells to in vivo differentiate also in endothelial cells. In conclusion, we demonstrate that CD105 + cells and clones derived from renal carcinomas were enriched in tumor‐initiating cells with stem characteristics.—Bussolati, B., Bruno, S., Grange, C., Ferrando, U., Camussi, G. Identification of a tumor‐initiating stem cell population in human renal carcinomas. FASEB J. 22, 3696–3705 (2008)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Multilineage potential of adult human mesenchymal stem cells
Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., Moorman, M. A., Simonetti, D. W., Craig, S., & Marshak, D. R. (1999) · Science · doi:10.1126/science.284.5411.143 · Cited by 21,052
Cited by
Targeting cancer stem cell pathways for cancer therapy
Yang, L., Shi, P., Zhao, G., Xu, J., Peng, W., Zhang, J., Zhang, G., Wang, X., Dong, Z., Chen, F., et al. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0110-5 · Cited by 1,906
Tumor angiogenesis: molecular pathways and therapeutic targets
Weis, S. M., & Cheresh, D. A. (2011) · Nature Medicine · doi:10.1038/nm.2537 · Cited by 1,736
Grange, C., Tapparo, M., Collino, F., Vitillo, L., Damasco, C., Deregibus, M. C., Tetta, C., Bussolati, B., & Camussi, G. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0241 · Cited by 851
Self-citationCairns, P. (2011) · Cancer Biomarkers · doi:10.3233/cbm-2011-0176 · Cited by 485
Cancer stem cells: problems for therapy?
Alison, M. R., Lim, S. M., & Nicholson, L. J. (2011) · The Journal of Pathology · doi:10.1002/path.2793 · Cited by 312
Metadata
- Authors
- Bussolati, B., Bruno, S., Grange, C., Ferrando, U., & Camussi, G.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2008-07-09
- Volume
- 22
- Issue
- 10
- Pages
- 3696-3705
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W1973607597
- Cited by
- 336
- References
- 1
- FWCI
- 6.78
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Identification of a tumor‐initiating stem cell population in human renal carcinomas. https://app.cochat.ai/papers/10.1096/fj.08-102590
- The paper
- Bussolati, B., Bruno, S., Grange, C., Ferrando, U., & Camussi, G. (2008). Identification of a tumor‐initiating stem cell population in human renal carcinomas. The FASEB Journal. https://doi.org/10.1096/fj.08-102590
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.